Addendum to "Emerging evidence for astrocyte dysfunction in schizophrenia"
- PMID: 36217806
- PMCID: PMC10117557
- DOI: 10.1002/glia.24275
Addendum to "Emerging evidence for astrocyte dysfunction in schizophrenia"
Erratum for
-
Emerging evidence for astrocyte dysfunction in schizophrenia.Glia. 2022 Sep;70(9):1585-1604. doi: 10.1002/glia.24221. Epub 2022 May 30. Glia. 2022. PMID: 35634946 Free PMC article. Review.
References
-
- Balu, D. T. , Pantazopoulos, H. , Huang, C. , Muszynski, K. , Harvey, T. L. , Uno, Y. , Rorabaugh, J. M. , Rorabaugh, J. M. , Galloway, C. R. , Botz‐Zapp, C. , Beretta, S. , Weinshenker, D. , & Coyle, J. T. (2019). Neurotoxic astrocytes express the D‐serine synthesizing enzyme, serine racemase, in Alzheimer's disease. Neurobiology of Disease, 130, 104511. 10.1016/j.nbd.2019.104511 - DOI - PMC - PubMed
-
- Benneyworth, M. A. , Yan, L. , Alo, C. B. , Vadim, Y. B. , & Joseph, T. C. (2012). Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons. Cellular and Molecular Neurobiology, 32, 613–624. 10.1007/s10571-012-9808-4.Cel - DOI - PMC - PubMed
-
- Dun, Y. , Duplantier, J. , Roon, P. , Martin, P. M. , Ganapathy, V. , & Smith, S. B. (2008). Serine racemase expression and D‐serine content are developmentally regulated in neuronal ganglion cells of the retina. Journal of Neurochemistry, 104(4), 970–978. 10.1111/j.1471-4159.2007.05015.x - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources